• 1
    Hazra S, Chilaka VN, Rajendran S, Konje JC. Massive postpartum haemorrhage as a cause of maternal morbidity in a large tertiary hospital. J Obstet Gynaecol 2004; 24: 51920.
  • 2
    Zhang WH, Alexander S, Bouvier-Colle MH, Macfarlane A. Incidence of severe preeclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: the MOMS-B survey. BJOG 2005; 112: 8996.
  • 3
    Alamia V, Meyer BA. Peripartum hemorrhage. Obstet Gynecol Clin North Am 1999; 26: 38598.
  • 4
    Langer B, Boudier E, Haberstich R, Dreyfus M. Obstetrical management in the event of persistent or worsening postpartum hemorrhage despite initial measures [French]. J Gynecol Obstet Biol Reprod 2004; 33: 4S7379.
  • 5
    Rizvi F, Mackey R, Barrett T, McKenna P, Geary M. Successful reduction of massive postpartum haemorrhage by use of guidelines and staff education. BJOG 2004; 111: 4958.
  • 6
    Lynn M, Jeroukhimov I, Klein Y, Martinowitz U. Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med 2002; 28: S2417.
  • 7
    Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16: 15368.
  • 8
    Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004; 114: 40914.
  • 9
    Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997; 73: 316.
  • 10
    Gerbasi FR, Bottoms S, Farag A, Mammen EF. Changes in hemostasis activity during delivery and the immediate postpartum period. Am J Obstet Gynecol 1990; 162: 115863.
  • 11
    Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 58692.
  • 12
    Kobayashi T, Terao T, Maki M, Ikenoue T. Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost 2001; 27: 1617.
  • 13
    Fagon JY, Chastre J, Novara A, Medioni P, Gibert C. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 1993; 19: 13744.
  • 14
    Montes R, Paramo JA, Angles-Cano E, Rocha E. Development and clinical application of a new ELISA assay to determine plasmin-alpha2-antiplasmin complexes in plasma. Br J Haematol 1996; 92: 97985.
  • 15
    Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case–control study. BMJ 2001; 322: 108993.
  • 16
    Duthie SJ, Ven D, Yung GL, Guang DZ, Chan SY, Ma HK. Discrepancy between laboratory determination and visual estimation of blood loss during normal delivery. Eur J Obstet Gynecol Reprod Biol 1991; 38: 11924.
  • 17
    Reyal F, Deffarges J, Luton D, Blot P, Oury JF, Sibony O. Severe post-partum hemorrhage: descriptive study at the Robert-Debre Hospital maternity ward [French]. J Gynecol Obstet Biol Reprod 2002; 31: 35864.
  • 18
    Combs CA, Murphy EL, Laros Jr RK. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991; 77: 6976.
  • 19
    Bouvier-Colle MH, Ould El Joud D, Varnoux N, Goffinet F, Alexander S, Bayoumeu F, Beaumont E, Fernandez H, Lansac J, Levy G, Palot M. Evaluation of the quality of care for severe obstetrical haemorrhage in three French regions. BJOG 2001; 108: 898903.
  • 20
    Levi M, Ten Cate H, Van Der Poll T, Van Deventer SJ. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270: 9759.
  • 21
    Macphail S, Talks K. Massive post-partum haemorrhage and management of disseminated intravascular coagulation. Curr Obstetr Gynaecol 2004; 14: 12331.
  • 22
    Andersson T, Lorentzen B, Hogdahl H, Clausen T, Mowinckel MC, Abildgaard U. Thrombin-inhibitor complexes in the blood during and after delivery. Thromb Res 1996; 82: 10917.
  • 23
    Epiney M, Boehlen F, Boulvain M, Reber G, Antonelli E, Morales M, Irion O, De Moerloose P. D-dimer levels during delivery and the postpartum. J Thromb Haemost 2005; 3: 26871.
  • 24
    Simon L, Santi TM, Sacquin P, Hamza J. Pre-anaesthetic assessment of coagulation abnormalities in obstetric patients: usefulness, timing and clinical implications. Br J Anaesth 1997; 78: 67883.
  • 25
    Dempfle CE, Zips S, Ergul H, Heene DL. The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer. Thromb Haemost 2001; 86: 12049.
  • 26
    Sher G. Trasylol in the management of abruptio placentae with consumption coagulopathy and uterine inertia. J Reprod Med 1980; 25: 1138.